Myriad Genetic Laboratories Inc.
Salt Lake City, UT Part of Myriad Genetics Inc.
- UEI
- H7C7T3D6ZSB8
- CAGE
- 1UFV3
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
-
Its parent company, Myriad Genetics Inc., ranks #69 in PSC 6632
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
Salt Lake City, UT
DGD1LL6KYLC8
-
Parent
Salt Lake City, UT
DGD1LL6KYLC8
- SAM.gov registration date
- Physical address
- 322 N 2200 W, Salt Lake City, UT 84116, USA
- Website
- myriad.com
- Founded
- 1991
- Employees
- 1K-5K
- Estimated annual revenue
- $500M-$1B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | -$84,280 |
| FY2025 | $17,986 |
| FY2024 | -$107,772 |
| FY2023 | $16,772 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Myriad Genetics Inc. | Salt Lake City, UT | 621511 Medical Laboratories |
| Invitae Corporation | — | 621511 Medical Laboratories |
| Athena Diagnostics, Inc. | Marlborough, MA | 621511 Medical Laboratories |
| Fulgent Genetics, Inc. | El Monte, CA | 621511 Medical Laboratories |
| Biotheranostics Inc. | San Diego, CA | 621511 Medical Laboratories |
About the company
Myriad Genetic Laboratories Inc. is a subsidiary of Myriad Genetics Inc., a for-profit organization specializing in personalized medicine and genetic testing services. The company is registered in the System for Award Management (SAM.gov) and provides advanced genetic testing solutions to federal healthcare agencies. Located in Salt Lake City, Utah, Myriad Genetic Laboratories focuses on delivering precision medicine services, with a particular emphasis on cancer risk assessment and diagnostic testing.
Through its federal contract awards, Myriad Genetic Laboratories has primarily provided Prolaris prostate cancer testing services to the Department of Veterans Affairs (VA) across multiple Veterans Integrated Service Networks (VISN). These contracts, which have been competitively awarded without set-aside designations, involve delivering genomic testing that helps stratify disease risks and support clinical treatment decisions for veterans. The company has consistently been awarded contracts by VA healthcare systems in regions including VISN 12 and VISN 19, with contract values ranging from $2,499 to $122,672. Additionally, Myriad has expanded its federal contract portfolio to include laboratory services for the Indian Health Service (IHS), demonstrating its capability to support healthcare delivery to diverse patient populations.
Myriad Genetic Laboratories holds two primary federal contract Indefinite Delivery Vehicles (IDVs) with the VA. The first is an Indefinite Delivery Contract (IDC) with VISN 12, valued at $149,600 and effective through November 30, 2026, which allows systematic procurement of genetic testing services. The second is a Blanket Purchase Agreement (BPA) with VISN 19, valued at $74,970 and extending through April 30, 2026, specifically for Prolaris prostate cancer testing at the Salt Lake City VA Medical Center. These IDVs enable the VA to efficiently access Myriad's specialized genetic testing capabilities across multiple regions, supporting comprehensive healthcare delivery and treatment planning for veterans through standardized, competitively awarded contract vehicles.
Quick answers
Is Myriad Genetic Laboratories Inc. registered in SAM.gov?
Yes. Myriad Genetic Laboratories Inc.'s SAM.gov registration is active through March 4, 2027.
How much has Myriad Genetic Laboratories Inc. received in federal contracts?
Federal contracts obligated $17,986 to Myriad Genetic Laboratories Inc. in fiscal year 2025.
How does Myriad Genetic Laboratories Inc. rank among federal contractors?
Myriad Genetic Laboratories Inc.'s parent company, Myriad Genetics Inc., ranked #69 in PSC 6632 in FY2025.
What is Myriad Genetic Laboratories Inc.'s most recent federal award?
Myriad Genetic Laboratories Inc.'s most recent federal contract award is Prolaris prostate cancer testing for slcvamc ordering period 5 (36C25925N0118), from Veterans Integrated Service Network 19 (VHA), on May 1, 2025.
On GovTribe
See Myriad Genetic Laboratories Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors